Addressing The Challenge Of Scalability In Viral Vectors

Early viral vector process development for cell and gene therapies is critical to assure a production strategy that supports commercial needs.

In this webinar, you will learn:

• The importance of planning for scalability and manufacturability from the earliest stages of process development
• How a scalable templated process can reduce time needed to move from product development to commercialization.